NCT00380978

Brief Summary

The purpose of this study in nulliparous women undergoing induction of labor is to determine whether initiation of neuraxial analgesia compared to systemic opioid analgesia early in labor (\< 4 cm cervical dilation)affects the cesarean delivery rate.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,026

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2001

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2001

Completed
5 years until next milestone

First Submitted

Initial submission to the registry

September 25, 2006

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 27, 2006

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2008

Completed
3.3 years until next milestone

Results Posted

Study results publicly available

December 8, 2011

Completed
Last Updated

April 14, 2014

Status Verified

March 1, 2014

Enrollment Period

6.9 years

First QC Date

September 25, 2006

Results QC Date

July 5, 2011

Last Update Submit

March 17, 2014

Conditions

Keywords

labor paincesarean sectionepidural analgesiaopioid analgesicslocal anestheticslabor induced

Outcome Measures

Primary Outcomes (1)

  • Delivered by Cesarean Section

    The decision to proceed to operative delivery was made by the obstetric team for maternal or fetal indications.

    Time form initiation of labor analgesia to delivery (up to 24 hours)

Secondary Outcomes (7)

  • Instrumented Vaginal Delivery

    At time of decision for delivery

  • Duration of Labor

    Initiation of induction of labor to time of delivery

  • Indication for Cesarean Delivery

    At time of decision for delivery

  • Analgesia Efficacy

    At first and second analgesia requests

  • Nausea

    At second analgesia request

  • +2 more secondary outcomes

Study Arms (2)

early analgesia:combined-spinal epidural

ACTIVE COMPARATOR
Procedure: combined spinal epidural analgesia

late analgesia (systemic)

ACTIVE COMPARATOR
Procedure: late analgesia (systemic)

Interventions

Analgesia was initiated in the early group using a standard needle-through-needle technique with intrathecal fentanyl 25 mcg and an epidural test dose of lidocaine 15 mg/ml and epinephrine 5 mcg/ml in 3ml. At the second analgesia request, the cervix was examined. Epidural analgesia was initiated with a dilute bupivicaine/fentanyl solution if the cervix was less than 4 cm. If the cervix was 4 cm or more, epidural analgesia was initiated with bupivicaine 1.25 mg/ml. If no cervical exam was performed at the second request for analgesia, the cervix was assumed to be at least 4 cm dilated. Thereafter, analgesia was maintained in all participants in the early group with patient-controlled epidural analgesia.

Also known as: CSE
early analgesia:combined-spinal epidural

Analgesia was initiated in the late group with hydromorphone 1mg intramuscularly (IM) and 1 mg intravenously (IV). If the cervix was less than 4 cm at the second analgesia request, hydromorphone analgesia was repeated. Epidural analgesia was initiated with bupivicaine 1.25 mg/ml if the cervix was 4 cm or more. At the third analgesia request, epidural analgesia was initiated regardless of cervical dilation. Thereafter, epidural analgesia was maintained with patient controlled analgesia until delivery.

Also known as: Dilaudid, narcotic
late analgesia (systemic)

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • induction of labor
  • nulliparity
  • \>36 weeks gestation
  • singleton
  • vertex position
  • cervical dilation \< 4 cm at first request for analgesia
  • desires neuraxial analgesia

You may not qualify if:

  • spontaneously laboring
  • multiparity
  • nonvertex presentation
  • at or \>4cm at analgesia request
  • chronic opioid therapy
  • acute opioid therapy within 4 hours of analgesia request
  • allergy to study drugs (hydromorphone, fentanyl, bupivacaine, lidocaine)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Northwestern Memorial Hospital

Chicago, Illinois, 60611, United States

Location

Related Publications (1)

  • Wong CA, Scavone BM, Peaceman AM, McCarthy RJ, Sullivan JT, Diaz NT, Yaghmour E, Marcus RJ, Sherwani SS, Sproviero MT, Yilmaz M, Patel R, Robles C, Grouper S. The risk of cesarean delivery with neuraxial analgesia given early versus late in labor. N Engl J Med. 2005 Feb 17;352(7):655-65. doi: 10.1056/NEJMoa042573.

    PMID: 15716559BACKGROUND

MeSH Terms

Conditions

Labor Pain

Interventions

HydromorphoneNarcotics

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Morphine DerivativesMorphinansOpiate AlkaloidsAlkaloidsHeterocyclic CompoundsHeterocyclic Compounds, Bridged-RingHeterocyclic Compounds, 4 or More RingsHeterocyclic Compounds, Fused-RingPhenanthrenesPolycyclic Aromatic HydrocarbonsPolycyclic CompoundsCentral Nervous System DepressantsPhysiological Effects of DrugsPharmacologic ActionsChemical Actions and UsesAnalgesicsSensory System AgentsPeripheral Nervous System AgentsCentral Nervous System AgentsTherapeutic Uses

Limitations and Caveats

The study was not powered to detect a small difference between groups in the cesarean delivery rate. It was not blinded. Different obstetric providers have different management styles, and different triggers for performing cesarean delivery.

Results Point of Contact

Title
Dr. Robert J. McCarthy
Organization
Department of Anesthesiology; Northwestern University Feinberg School of Medicine

Study Officials

  • Cynthia A Wong, MD

    Northwestern University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Anesthesiology

Study Record Dates

First Submitted

September 25, 2006

First Posted

September 27, 2006

Study Start

October 1, 2001

Primary Completion

September 1, 2008

Study Completion

September 1, 2008

Last Updated

April 14, 2014

Results First Posted

December 8, 2011

Record last verified: 2014-03

Locations